A Study of LY3437943 in Participants With Type 2 Diabetes

Clinical trial NCT04867785 · COMPLETED

Trial details

NCT number: NCT04867785
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-05-13
Primary completion: 2022-07-08
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.